Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $8.2500 (-3.06%) ($7.6100 - $9.0900) on Fri. Mar. 13, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.61% (three month average) | RSI | 50 | Latest Price | $8.2500(-3.06%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.1% a day on average for past five trading days. | Weekly Trend | CGEN advances 5.8% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) ARKG(67%) ARKK(65%) XBI(65%) IBB(60%) IPO(57%) | Factors Impacting CGEN price | CGEN will decline at least -2.805% in a week (0% probabilities). VXX(-38%) VIXM(-34%) UUP(-12%) TLT(-4%) SHY(-4%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.805% (StdDev 5.61%) | Hourly BBV | 0 () | Intraday Trend | -7.6% | | | |
|
Resistance Level | $9.56 | 5 Day Moving Average | $10.05(-17.91%) | 10 Day Moving Average | $9.79(-15.73%) | 20 Day Moving Average | $9.56(-13.7%) | To recent high | -30.3% | To recent low | 50.8% | Market Cap | $682m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |